Clinical Trial Update: A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 safety study evaluating a DNA vaccine for herpes simplex virus type 2 delivered by particle-mediated delivery …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Virus Type Infection

Drugs mentioned

• PowderMed HSV-2 DNA Vaccine (DNA vaccine encoding HSV-2 antigen)

Snippet

Sponsor: PowderMed | Conditions: HSV-2 | Phase 1 | Status: COMPLETED